SYSTEMS AND METHODS FOR GENE EXPRESSION AND TISSUE OF ORIGIN INFERENCE FROM CELL-FREE DNA

    公开(公告)号:WO2023091517A2

    公开(公告)日:2023-05-25

    申请号:PCT/US2022/050151

    申请日:2022-11-16

    IPC分类号: C12Q1/686 G16B20/00

    摘要: Methods are provided for non-invasively determining the expression of genes of interest by inference and the use thereof in disease classification and stratification for treatment. Disclosed methods relate to assessment of fragment length diversity of cell-free DNA, such as determining promoter fragment entropy (PFE). Fragment length diversity scores may be combined with nucleosome depleted region depth to produce a metric that is indicative of gene expression. In some embodiments, the methods use only noninvasive blood draws and identify which patients will achieve durable clinical benefit from immune checkpoint inhibition, what the cancer subtype classification is, and/or what the tumor burden is. In an embodiment, the methods further comprise selecting a treatment regimen for the individual based on the analysis. Also disclosed are bait sets for enrichment of cell-free DNA from regions in proximity with transcription start sites.

    細胞培養装置、細胞培養のためのキット及び細胞培養方法

    公开(公告)号:WO2023090388A1

    公开(公告)日:2023-05-25

    申请号:PCT/JP2022/042675

    申请日:2022-11-17

    摘要: 本発明の課題は、難培養性の嫌気性の細菌の生体における生育・増殖環境をin vitroで再現することができる細胞培養装置、細胞培養のためのキット及び細胞培養方法を提供することである。本発明によれば、培地を収容するための凹部を有するプレート、ガス透過膜を有する細胞収容容器、上記細胞収容容器を保持するための第一の部材、及び上記細胞収容容器の上部空間のガス濃度を調節するための構造を有する第二の部材を含む、細胞培養装置であって、上記ガス透過膜の上面に細胞シートを形成した場合には、上記ガス透過膜より上部の空間が、ガスが透過しない密封状態になる、細胞培養装置が提供される。

    一种筛选黄绿卷毛菇总多酚含量指标的DNA条形码

    公开(公告)号:WO2023087784A1

    公开(公告)日:2023-05-25

    申请号:PCT/CN2022/109894

    申请日:2022-08-03

    申请人: 杨满军

    摘要: 本发明公开了一种筛选黄绿卷毛菇总多酚含量指标的DNA条形码、引物组及应用。本发明的DNA条形码技术具有省时、省力、省钱、准确、高效的优点,在优质黄绿卷毛菇原产地鉴别和遗传育种上发挥积极作用,同时也为种质资源的鉴定及保护提供了一种有效方法。

    METHODS OF ASSESSING SMOLDERING MULTIPLE MYELOMA

    公开(公告)号:WO2023087105A1

    公开(公告)日:2023-05-25

    申请号:PCT/CA2022/051694

    申请日:2022-11-16

    摘要: Provided are methods for prognosing a clinical outcome in a subject or diagnosing the subject with high-risk or stable smoldering multiple myeloma (SMM), comprising determining a 3D telomeres organization signature of a test sample from the subject, the test sample comprising plasma cells, applying a classification model to the 3D telomeres organization signature to obtain an output classification that is indicative of the clinical outcome or diagnosis of the subject. Also provided are methods for treating a subject with high-risk or stable SMM.